ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1448
1,09%
Bitcoin
62.381,27
1,95%
Brent Oil
83,995
0,52%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. bluebird bio Inc (BLUE)

  7. bluebird bio Inc (BLUE) Notícias

BLUE

bluebird bio (BLUE)

bluebird bio Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BLUE
DataHoraFonteTítuloCódigoCompanhia
09/05/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLUEbluebird bio Inc
09/05/202408:00Business Wirebluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 GuidanceNASDAQ:BLUEbluebird bio Inc
07/05/202406:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUENASDAQ:BLUEbluebird bio Inc
06/05/202408:05Business Wirebluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor EventsNASDAQ:BLUEbluebird bio Inc
06/05/202408:00Business Wirebluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene TherapyNASDAQ:BLUEbluebird bio Inc
03/05/202406:45PR Newswire (US)Class Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:BLUEbluebird bio Inc
26/04/202417:05Business Wirebluebird bio Announces Receipt of Expected Notice from NasdaqNASDAQ:BLUEbluebird bio Inc
26/04/202406:45PR Newswire (US)BLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:BLUEbluebird bio Inc
19/04/202406:45PR Newswire (US)bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUENASDAQ:BLUEbluebird bio Inc
16/04/202406:45PR Newswire (US)Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:BLUEbluebird bio Inc
12/04/202406:45PR Newswire (US)Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:BLUEbluebird bio Inc
11/04/202409:00Business Wirebluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BLUEbluebird bio Inc
09/04/202406:45PR Newswire (US)bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUENASDAQ:BLUEbluebird bio Inc
05/04/202406:45PR Newswire (US)Shareholders that lost money on bluebird bio, Inc.(BLUE) should contact The Gross Law Firm about pending Class Action - BLUENASDAQ:BLUEbluebird bio Inc
26/03/202408:01Business Wirebluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 GuidanceNASDAQ:BLUEbluebird bio Inc
25/03/202417:05Business Wirebluebird bio to Host Fourth Quarter and 2023 Annual Results Conference CallNASDAQ:BLUEbluebird bio Inc
18/03/202409:00Business Wirebluebird bio Secures up to $175 Million Debt Financing with Hercules CapitalNASDAQ:BLUEbluebird bio Inc
11/03/202409:00Business Wirebluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene TherapyNASDAQ:BLUEbluebird bio Inc
05/03/202419:40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
14/02/202415:54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLUEbluebird bio Inc
08/01/202418:35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLUEbluebird bio Inc
08/01/202410:00Business Wirebluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial OutlookNASDAQ:BLUEbluebird bio Inc
02/01/202410:00Business Wirebluebird bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:BLUEbluebird bio Inc
20/12/202319:05Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BLUEbluebird bio Inc
19/12/202323:41Business Wirebluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common StockNASDAQ:BLUEbluebird bio Inc
19/12/202308:10IH Market NewsGoogle $700M Antitrust Settlement, TSMC Chairman Retirement, Tesla Nevada Wage Hike, and MoreNASDAQ:BLUEbluebird bio Inc
18/12/202318:01Business Wirebluebird bio, Inc. Announces Proposed Public Offering of Common StockNASDAQ:BLUEbluebird bio Inc
10/12/202314:02Business WireLong-Term Data Presented at ASH Support beti-cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb LevelsNASDAQ:BLUEbluebird bio Inc
09/12/202313:31Business WireLong-term Follow-up Data From bluebird’s Gene Therapy Program in Sickle Cell Disease Support Durable, Potentially Curative Benefits Through Stable Production of Anti-Sickling Adult Hemoglobin and Resolution of Vaso-Occlusive EventsNASDAQ:BLUEbluebird bio Inc
08/12/202318:11Dow Jones NewsBluebird Bio Shares Slide 41% on Black-Box Label, Higher Price for Sickle-Cell TreatmentNASDAQ:BLUEbluebird bio Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BLUE

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
PDTC3
Padtec ON
BOV
AZEV4
AZEVEDO PN
BOV
OIBR3
OI ON
BOV
VVEO3
CM Hospitalar ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
PRIO3
PETRORIO ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
ENJU3
Enjoei ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
ENAT3
ENAUTA ON
BOV
JHSF3
JHSF PART ON
BOV
SGPS3
SPRINGS ON
BOV
SHOW3
TIME FOR FUN ON
BOV
MGLU3
MAGAZINE LUIZA ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados